Drug intelligence / Profile preview

neomycin sulfate + fluocinonide

Development stage
Unknown
Lead developer
Guilin Hwasun Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

This topical combination product contains neomycin sulfate, an aminoglycoside antibiotic, and fluocinonide, a potent synthetic glucocorticoid. Developed by Guilin Hwasun Pharmaceutical, it is indicated for the treatment of inflammatory skin disorders complicated by bacterial infections, such as infected eczema, contact dermatitis, and seborrheic dermatitis. Neomycin provides antibacterial activity by binding to the bacterial 30S ribosomal subunit, thereby inhibiting protein synthesis. Fluocinonide exerts anti-inflammatory, antipruritic, and vasoconstrictive effects through the activation of the glucocorticoid receptor, which modulates the transcription of genes involved in the inflammatory response. The formulation is typically applied topically as a cream to the affected area.

Brand names
Fluocinonide and Neomycin Sulfate Cream
Other names
醋酸氟轻松新霉素乳膏
02

Targets

GR (Glucocorticoid receptor)Bacterial Ribosome

Beyond the preview

Go deeper on neomycin sulfate + fluocinonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + fluocinonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call